-

KD Investors: Kessler Topaz Meltzer & Check, LLP Reminds Investors of April 13, 2026 Deadline in Securities Fraud Class Action Lawsuit Filed Against Kyndryl Holdings, Inc.

Did you buy KD securities between August 7, 2024, and February 9, 2026?

Affected Kyndryl Holdings, Inc. Investor Summary

  • Who: Kyndryl Holdings, Inc. (NYSE: KD)
  • What: Securities fraud class action lawsuit filed
  • Class Period: August 7, 2024, through February 9, 2026
  • Deadline to Seek Lead Plaintiff Status: April 13, 2026
  • Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s cash management practices and internal control over financial reporting.
  • Investor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options at no cost to investor

RADNOR, Pa.--(BUSINESS WIRE)--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities fraud class action lawsuit has been filed against Kyndryl Holdings, Inc. (Kyndryl) (NYSE: KD) on behalf of those who purchased or acquired Kyndryl securities between August 7, 2024, and February 9, 2026, inclusive. The lawsuit is filed in the United States District Court for the Eastern District of New York and is captioned Brander v. Kyndryl Holdings, Inc., et al, Case No. 1:26-cv-00782 (E.D.N.Y.). Investors have until April 13, 2026, to file for lead plaintiff status.

CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC):

If you experienced losses in connection with Kyndryl Holdings, Inc., contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at info@ktmc.com or visit:

https://www.ktmc.com/kd-kyndryl-holdings-inc-class-action-lawsuit?utm_source=Businesswire&utm_medium=pressrelease&utm_campaign=kd&mktm=PR

KYNDRYL HOLDINGS, INC. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY:

The complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Kyndryl’s financial statements issued during the Class Period were materially misstated; (2) Kyndryl lacked adequate internal controls and at times materially understated issues with its internal controls; (3) as a result, Kyndryl would be unable to timely file its quarterly report on Form 10-Q with the SEC for the quarter ended December 31, 2025; and (4) as a result, Defendants’ statements about Kyndryl’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times.

WHAT KD INVESTORS CAN DO NOW:

  1. File to be lead plaintiff by April 13, 2026.
  2. Contact KTMC for a free case evaluation.
  3. Retain counsel of choice or take no action.

THE LEAD PLAINTIFF PROCESS FOR KYNDRYL HOLDINGS, INC. INVESTORS:

Kyndryl investors may, no later than April 13, 2026, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP encourages Kyndryl investors to contact the firm for more information.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC):

Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.

Contacts

Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
info@ktmc.com

Kessler Topaz Meltzer & Check, LLP

NYSE:KD

Release Versions
$Cashtags

Contacts

Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
info@ktmc.com

More News From Kessler Topaz Meltzer & Check, LLP

uniQure N.V. (QURE) Investors: Kessler Topaz Meltzer & Check, LLP Announces That the Firm Has Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. and Encourages Investors to Contact the Firm

RADNOR, Pa.--(BUSINESS WIRE)--Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against uniQure N.V. (NASDAQ: QURE) (“uniQure” or the “Company”) on behalf of investors who purchased or acquired uniQure ordinary shares between September 24, 2025, and October 31, 2025, inclusive (the “Class Period”). This action, captioned Scocco v. uniQure N.V., et al., Case No. 1:26-cv-01124, was filed in the United States District Court for...

RARE Investors: Kessler Topaz Meltzer & Check, LLP Reminds Investors of April 6, 2026 Deadline in Securities Fraud Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc.

RADNOR, Pa.--(BUSINESS WIRE)--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities fraud class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. (Ultragenyx) (NASDAQ: RARE) on behalf of those who purchased or acquired Ultragenyx common stock between August 3, 2023, and December 26, 2025, inclusive. The lawsuit is filed in the United States District Court for the Northern District of California and is captioned Bailey v. Ultragenyx Pharmace...

NYSE: RAL Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Ralliant Corporation (NYSE: RAL) Investors to Contact the Firm

RADNOR, Pa.--(BUSINESS WIRE)--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Ralliant Corporation (NYSE: RAL). On February 4, 2026, Ralliant Corporation reported its fourth quarter and full year 2025 financial results and revealed a $1.4 billion non-cash goodwill impairment charge recorded in the Test & Measurement segment, which the company stated was mainly driven by revised exp...
Back to Newsroom